Biotech and biomedicine

Central Bohemia is a key driver of biotechnological and biomedical research in Czechia.

Thanks to the collaboration of top research institutions and high-tech companies, innovations created here are changing the world, addressing serious diseases and improving the quality of human life. A prime example of this synergy is the BIOCEV Biotechnology and Biomedical Centre, a European centre of excellence focusing on applied research and the development of new therapies. Its breakthrough projects include a promising drug to treat the most aggressive forms of breast cancer and a new generation of antibiotics, which BIOCEV is developing with the Central Bohemian start-up SigutLabs.

Central Bohemia is also home to DIANA Biotechnologies, a spin-off company which became one of the largest Czech producers of PCR tests during the Covid-19 pandemic. Other pioneering healthcare innovations are being developed at the Faculty of Biomedical Engineering of the Czech Technical University in Prague and biotech start-ups are also thriving in the InnoCrystal science and technology park.

The number of PCR tests produced by the Central Bohemian company DIANA Biotechnologies.

Number of scientific papers published by the research teams of the Central Bohemian BIOCEV Centre (including in high-impact international journals)

The number of globally unique molecules produced by the Central Bohemian start-up Santiago Labs.

The number of PCR tests produced by the Central Bohemian company DIANA Biotechnologies.

Number of scientific papers published by the research teams of the Central Bohemian BIOCEV Centre (including in high-impact international journals)